LYC Healthcare Berhad announces that its 64.5% owned subsidiary, LYC Medicare Singapore Limited has lodged the preliminary offer document with the Singapore Exchange Limited Catalist Board.
The group said the strategic initiative is anticipated to support further growth and expansion plans for LYC Healthcare, enhancing liquidity and access to capital markets. Additionally, it is anticipated to elevate LYC Healthcare’s brand presence in Singapore, fostering greater awareness among consumers and investors in the region.
Mr. Sui Dong Hoe, Manging Director cum Group Chief Executive Officer of LYC Healthcare highlighted: ” Lodging LYC Medicare Singapore’s offer document with the SGX marks a significant phase in LYC Healthcare’s journey. It aligns with our vision to strengthen our brand in the Southeast Asian healthcare landscape. We are eager to embark on this journey, confident that it will enrich our market presence in Singapore and reinforce our commitment to delivering superior healthcare services across the region.”
As at 5:00 P.M. 29 March 2024, LYC Healthcare’s share price closed at RM0.185, equivalent to a total market capitalisation of RM128.1 million.
